FDA NDA · NDA205508

ATAZANAVIR SULFATE; RITONAVIR

Sponsor: EMCURE PHARMS LTD

APPLICATION

NDA205508

TYPE

NDA

ROUTE

ORAL

DOSAGE FORM

TABLET

MARKETING STATUS

None (Tentative Approval)

Products

ATAZANAVIR SULFATE; RITONAVIRNone (Tentative Approval)

ATAZANAVIR SULFATE 300MG, RITONAVIR 100MG · TABLET · ORAL

2014-03-17Type 4 - New Combination · Original · priority — Letter ↗TA

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.